An infant with precursor natural killer (NK) cell leukemia successfully treated with an unrelated cord blood transplantation

Leukemia and Lymphoma

Volumn 39, Issue 5-6, 2000, Pages 641-646

  Suminoe, A ^a   Matsuzaki, A ^a   Takada, H ^a   Hattori, H ^a   Furuno, K ^a   Takemoto, M ^a   Maki, H ^a   Kanaya, N ^a   Ohnuma, K ^a   Nishihira, H ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cord blood transplantation; Immunophenotype; Infant; NK cell receptors; Precursor NK cell leukemia

Indexed keywords

BUSULFAN; CD16 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN; MELPHALAN; METHOTREXATE; MITOXANTRONE; PIRARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CELL GRANULE; CHILDHOOD LEUKEMIA; CYTOMEGALOVIRUS INFECTION; CYTOPLASM; CYTOTOXICITY; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HEPATOSPLENOMEGALY; HUMAN; IMMUNOPHENOTYPING; INFANT; JAPAN; LEUKEMIA CELL; MALE; NATURAL KILLER CELL; PARANASAL SINUS TUMOR; PRIORITY JOURNAL; PROLYMPHOCYTE; TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VIRUS PNEUMONIA;

EID: 0034486845     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009113395     Document Type: Article

References (15)

1. Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells
2. Clonal diseases of large granular lymphocytes
3. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology
4. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
5. The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms
6. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
7. Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study
8. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity
9. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
10. NK cell receptors
11. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
12. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
13. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells
14. Aggressive natural killer (NK) cell lymphoma: Report of a pediatric case and review of the literature
15. Classification of natural killer (NK) cell and NK-like T-cell malignancies